Unilever PLC Form 6-K summary
Business context and reporting period
Filed on 3 November 2026, this Form 6-K reports transactions in Unilever shares by Trian Fund Management, L.P., a person closely associated with Unilever director Nelson Peltz. The disclosed transactions occurred on 28–30 October 2026 and were related to the expiration of a Trian-managed fund.
Financial performance and position
This filing contains no financial results, cash flow, margin, debt, liquidity, or guidance information. It does not provide a clear value for Unilever’s financial performance or position.
Transactions disclosed
- On 28 October, Trian sold 1,552,427 ordinary shares on the London Stock Exchange at a weighted-average price of £47.67, for reported aggregate consideration of £73,999,870.
- On 29 October, Trian sold 464,481 ordinary shares on the London Stock Exchange at a weighted-average price of £47.98, for reported aggregate consideration of £22,287,727.
- On 30 October, Trian sold 1,600,000 ordinary shares on the London Stock Exchange at a weighted-average price of £48.73, for reported aggregate consideration of £77,968,681.
- On 30 October, a Trian-managed fund distributed 100,000 ordinary shares in specie, reported at £0.00 per share.
- A related swap settlement involved 335,519 ordinary shares: Trian reported a sale to a broker at £48.71 per share on 30 October, following short-swap transactions involving the same number of ADRs on 29 October. The filing describes these as related transactions and says their net result was settlement of a swap via disposition of the ordinary shares.
Changes, outlook, and risks
The disclosure concerns a fund’s expiration and associated share and swap transactions. It does not state Trian’s remaining holding, describe a change in Unilever’s strategy or operations, or provide company outlook, risk, or contingency updates.
Important facts for investors to verify
- Confirm Trian’s resulting beneficial ownership and any subsequent filings; this 6-K does not state its post-transaction shareholding.
- Distinguish the reported ordinary-share sales from the related ADR and swap activity to avoid double-counting the 335,519-share swap settlement.
- Note that the filing reports a 100,000-share in-specie distribution at £0.00; this is not described as a market sale.